Evidence map›Paper›PMID 35111625›Full record

ArticleQuantitative imaging in medicine and surgery2022

Personalized dosimetry for a deeper understanding of metastatic response to high activity

Bartolomeo Cassano, Milena Pizzoferro, Silvio Valeri, Claudia Polito, Salvatore Donatiello, Claudio Altini, Maria Felicia Villani, Annalisa Serra, Aurora Castellano, Maria Carmen Garganese and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 7 citations in OpenAlex.

  1. OptimizingNuclear medicine and molecular imaging · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Bartolomeo CassanoMedical Physics Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Milena PizzoferroNuclear Medicine Unit/Imaging Department, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Silvio ValeriMedical Physics Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Claudia PolitoMedical Physics Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Salvatore DonatielloMedical Physics Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Claudio AltiniNuclear Medicine Unit/Imaging Department, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Maria Felicia VillaniNuclear Medicine Unit/Imaging Department, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Annalisa SerraDepartment of Pediatric Hematology and Oncology, IRCCS Ospedale Pediatrico Bambino Gesu, Rome, Italy.
Aurora CastellanoNuclear Medicine Unit/Imaging Department, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Maria Carmen GarganeseNuclear Medicine Unit/Imaging Department, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Vittorio CannatàMedical Physics Unit, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.
Bambino Gesù Children's Hospital · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDosimetry in molecular radiotherapy for personalized treatment is assuming a central role in clinical management of aggressive/relapsed tumors. Relapsed/refractory metastatic high-risk neuroblastoma (rrmHR-NBL) has a poor prognosis and high-activity

methodsFourteen patients affected by rrmHR-NBL were treated with high-activity

resultsThe cumulative

conclusionsOur experience demonstrated feasibility of high activity therapy of

Indexed as

131I-mIBG high activity therapydose-response correlationDosimetryhigh risk neuroblastoma

Identifiers

PMID35111625
PMCPMC8739146
OpenAlexW3214305857

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.